Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
2664 Cawachi
- 2560
- +3+0.12%
20min DelayMarket Closed Dec 30 15:30 JST
62.93BMarket Cap12.14P/E (Static)
2582High2558Low47.40KVolume2564Open2557Pre Close121.60MTurnover301052wk High0.38%Turnover Ratio24.58MShares241552wk Low195.95EPS TTM32.35BFloat Cap5600Historical High12.14P/E (Static)12.64MShs Float1149Historical Low210.79EPS LYR0.94%Amplitude80.00Dividend TTM0.51P/B100Lot Size3.13%Div YieldTTM
Cawachi Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 15, 2024 | (Q1)Jun 15, 2024 | (FY)Mar 15, 2024 | (Q4)Mar 15, 2024 | (Q3)Dec 15, 2023 | (Q2)Sep 15, 2023 | (Q1)Jun 15, 2023 | (FY)Mar 15, 2023 | (Q4)Mar 15, 2023 | (Q3)Dec 15, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.89%76.04B | 1.09%71.34B | 1.45%285.96B | 1.06%70.13B | -0.03%69.9B | 2.23%75.37B | 2.51%70.56B | 0.86%281.87B | 2.11%69.4B | 4.17%69.92B |
| Cost of revenue | 0.61%58.59B | 0.87%55B | 1.07%220.16B | 0.24%53.72B | -0.50%53.69B | 2.32%58.23B | 2.16%54.52B | 0.70%217.82B | 2.65%53.59B | 4.01%53.96B |
| Gross profit | 1.84%17.45B | 1.83%16.34B | 2.74%65.8B | 3.83%16.41B | 1.57%16.21B | 1.92%17.14B | 3.72%16.05B | 1.42%64.05B | 0.30%15.8B | 4.73%15.96B |
| Operating expense | 3.10%14.95B | 3.11%14.74B | 1.33%58.2B | -0.61%14.88B | 2.24%14.53B | 1.04%14.5B | 2.79%14.29B | 3.60%57.44B | 4.66%14.97B | 5.73%14.21B |
| Selling and administrative expenses | ---- | 3.11%14.74B | ---- | ---- | ---- | ---- | --14.29B | ---- | ---- | ---- |
| -General and administrative expense | ---- | 3.11%14.74B | ---- | ---- | ---- | ---- | --14.29B | ---- | ---- | ---- |
| Operating profit | -5.08%2.5B | -8.55%1.61B | 14.96%7.6B | 83.65%1.53B | -3.94%1.68B | 7.06%2.64B | 12.00%1.76B | -14.24%6.61B | -42.70%832M | -2.72%1.75B |
| Net non-operating interest income (expenses) | 25.00%-3M | 0.00%-4M | 20.00%-16M | 0.00%-4M | 33.33%-4M | 0.00%-4M | 33.33%-4M | 20.00%-20M | 20.00%-4M | 0.00%-6M |
| Non-operating interest income | -20.00%4M | -20.00%4M | -9.52%19M | -20.00%4M | 0.00%5M | -16.67%5M | 0.00%5M | -12.50%21M | 0.00%5M | -16.67%5M |
| Non-operating interest expense | -22.22%7M | -11.11%8M | -14.63%35M | -11.11%8M | -18.18%9M | -10.00%9M | -18.18%9M | -16.33%41M | -10.00%9M | -8.33%11M |
| Net investment income | 0 | 0.00%1M | 50.00%3M | 0 | 100.00%2M | 0 | 0.00%1M | 0.00%2M | 0 | 0.00%1M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -24.20%-390M | 44.30%-44M | -35.43%-1.57B | -52.57%-1.13B | 3.70%-52M | -2.95%-314M | -25.40%-79M | -8.01%-1.16B | 23.92%-738M | -92.86%-54M |
| Less:Impairment of capital assets | 0.00%14M | -7.14%13M | -5.08%56M | -6.67%14M | -6.67%14M | -6.67%14M | 0.00%14M | -9.23%59M | -6.25%15M | -11.76%15M |
| Less:Other special charges | -15.59%249M | 144.29%31M | 109.47%398M | 321.88%135M | -2.56%38M | 321.43%295M | -242.86%-70M | 192.31%190M | 220.00%32M | 254.55%39M |
| Less:Write off | 1,300.00%70M | --0 | 22.61%1.12B | 41.39%977M | --0 | -97.73%5M | --135M | -3.50%911M | -26.80%691M | --0 |
| Other non-operating income (expenses) | -8.85%237M | -22.74%231M | -0.18%1.14B | -5.44%278M | 11.99%299M | -10.34%260M | 4.18%299M | 5.76%1.14B | 12.64%294M | -2.20%267M |
| Income before tax | -9.03%2.35B | -9.28%1.79B | 8.84%7.15B | 75.65%678M | -1.79%1.93B | 5.65%2.58B | 10.42%1.97B | -14.51%6.57B | -47.70%386M | -3.92%1.96B |
| Income tax | -4.02%811M | -7.61%607M | 1.92%2.44B | -13.97%271M | 0.45%667M | 4.58%845M | 8.24%657M | -16.21%2.39B | -41.99%315M | 0.45%664M |
| Net income | -11.48%1.54B | -10.13%1.18B | 12.83%4.71B | 481.43%407M | -2.85%1.26B | 6.18%1.73B | 11.46%1.31B | -13.52%4.18B | -64.29%70M | -5.95%1.3B |
| Net income continuous operations | -11.48%1.54B | -10.12%1.18B | 12.81%4.71B | 473.24%407M | -2.93%1.26B | 6.18%1.73B | 11.54%1.31B | -13.50%4.18B | -63.59%71M | -6.02%1.3B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -11.48%1.54B | -10.13%1.18B | 12.83%4.71B | 481.43%407M | -2.85%1.26B | 6.18%1.73B | 11.46%1.31B | -13.52%4.18B | -64.29%70M | -5.95%1.3B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -11.48%1.54B | -10.13%1.18B | 12.83%4.71B | 481.43%407M | -2.85%1.26B | 6.18%1.73B | 11.46%1.31B | -13.52%4.18B | -64.29%70M | -5.95%1.3B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -11.48%68.73 | -10.12%52.87 | 12.81%211.03 | 474.76%18.22 | -2.83%56.35 | 6.17%77.64 | 11.46%58.82 | -13.57%187.06 | -63.81%3.17 | -6.12%57.99 |
| Diluted earnings per share | -11.47%68.66 | -10.11%52.81 | 12.81%210.79 | 474.13%18.2 | -2.83%56.28 | 6.17%77.56 | 11.46%58.75 | -13.52%186.85 | -63.77%3.17 | -6.08%57.92 |
| Dividend per share | 0 | 0 | 60.00%80 | 60.00%80 | 0 | 0 | 0 | 0.00%50 | 0.00%50 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |